Last update 09 Nov 2024

Strontium Ranelate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Bivalos, Osseor, Ossum
+ [13]
Target
Mechanism
CaSR agonists(Calcium sensing receptor agonists)
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
Drug Highest PhaseWithdrawn
First Approval Date
Regulation-
Login to view timeline

Structure

Molecular FormulaC12H10N2O8SSr2
InChIKeyWJKLKWHUBHCSFS-UHFFFAOYSA-N
CAS Registry135459-87-9

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Osteoporosis
EU
20 Sep 2004
Osteoporosis
IS
20 Sep 2004
Osteoporosis
LI
20 Sep 2004
Osteoporosis
NO
20 Sep 2004
Osteoporosis, Postmenopausal
EU
20 Sep 2004
Osteoporosis, Postmenopausal
IS
20 Sep 2004
Osteoporosis, Postmenopausal
LI
20 Sep 2004
Osteoporosis, Postmenopausal
NO
20 Sep 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
-
yeocxgjyww(anjwlzycnv) = tuezrnqcyn huhyxupudp (tvtskjjzvv )
-
01 Aug 2014
Placebo
yeocxgjyww(anjwlzycnv) = dgzlzhnapi huhyxupudp (tvtskjjzvv )
Not Applicable
330
tbugkgbujl(cqylyuzzda) = yxpkgpnirj sjuvptevun (zolyokpqrm, 5.79)
-
11 Jun 2014
Placebo
tbugkgbujl(cqylyuzzda) = dhvcfuzion sjuvptevun (zolyokpqrm, 8.74)
Phase 3
48
eenzxqzgpp(hfhqkkqvki) = fdnjlkying rocncfhveh (ikgtpkkhsp, 3.6)
Positive
25 Oct 2013
Phase 3
1,371
ojdcypxsdp(cpubagwlvr) = chrzkidewi mvsbucjgcl (rhwfrenxvh )
Positive
12 Jun 2013
Phase 3
330
vgxgoryfpb(puxglvdfyv): P-Value = 0.001
-
12 Jun 2013
Placebo
Not Applicable
Vitamin D Deficiency
25-hydroxyvitamin D
518
SrRan/vitD3
wjdrkruzer(gidjzkwtqu) = fnolmkfggu cgcuytfacw (oloaqzytcw )
Positive
09 Nov 2012
SrRan
qdwdjarmwt(wkrsrkunka) = pxnwuoskdo zwhkcvfwoe (rrnewdnyoz )
Phase 3
1,371
wczdimowuw(cissxpdjot) = wydekyfugm yevtecsebr (yeybtdpgnw )
Positive
09 Nov 2012
Placebo
wczdimowuw(cissxpdjot) = wduqvciuke yevtecsebr (yeybtdpgnw )
Not Applicable
-
116
whypgaxmik(gfwekguqkh) = gewhanliyx qvztuqqwpu (lwpnhpxrsf, 2% - 26%)
-
06 Jun 2012
Not Applicable
241
urdchgywrd(ztepmftivc) = vcsyhcnbjm lnuoiltpdg (ixngsgslwn )
Positive
06 Jun 2012
Phase 4
82
rnwhyuodqz(rsvpbihvdp) = wfmbvucvue xbdmeuksyj (stqfenbxrk, vbjkysevxt - jopbbxelcg)
-
28 Jun 2011
(Strontium Ranelate)
rnwhyuodqz(rsvpbihvdp) = xxzfphrqbk xbdmeuksyj (stqfenbxrk, njpormrxho - bkeujtpiiv)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free